| Buy 5 Health and Fitness Stocks to Enhance Your Portfolio Returns |
Five Health and Fitness stocks to buy now are: SFM, DXCM, HIMS, UNFI, GDRX. |
zacks.com |
2025-05-12 14:10:52 |
Czytaj oryginał (ang.) |
| GDRX vs. PGNY: Which Stock Should Value Investors Buy Now? |
Investors looking for stocks in the Medical Services sector might want to consider either GoodRx Holdings, Inc. (GDRX) or Progyny (PGNY). But which of these two stocks is more attractive to value investors? |
zacks.com |
2025-05-08 16:40:29 |
Czytaj oryginał (ang.) |
| GoodRx Holdings, Inc. (GDRX) Q1 2025 Earnings Call Transcript |
GoodRx Holdings, Inc. (NASDAQ:GDRX ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Aubrey Reynolds – Director-Investor Relations Wendy Barnes – President and Chief Executive Officer Chris McGinnis – Chief Financial Officer Conference Call Participants Lisa Gill – JPMorgan John Ransom – RJF Charles Rhyee – TD Cowen Jailendra Singh – Truist Securities Craig Hettenbach – Morgan Stanley George Hill – Deutsche Bank Steven Valiquette – Mizuho Securities Allen Lutz – Bank of America Michael Cherny – Leerink Partners Daniel Grosslight – Citi Operator Ladies and gentlemen, thank you for standing by and welcome to the GoodRx First Quarter 2025 Earnings Call. As a reminder, today's conference is being recorded. |
seekingalpha.com |
2025-05-08 16:20:30 |
Czytaj oryginał (ang.) |
| Is GoodRx (GDRX) a Great Value Stock Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2025-05-08 14:40:47 |
Czytaj oryginał (ang.) |
| Compared to Estimates, GoodRx (GDRX) Q1 Earnings: A Look at Key Metrics |
Although the revenue and EPS for GoodRx (GDRX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-05-08 01:00:39 |
Czytaj oryginał (ang.) |
| GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates |
GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.08 per share a year ago. |
zacks.com |
2025-05-07 23:51:08 |
Czytaj oryginał (ang.) |
| GoodRx Holdings, Inc. (GDRX) Reports Next Week: Wall Street Expects Earnings Growth |
GoodRx (GDRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-04-30 15:06:40 |
Czytaj oryginał (ang.) |
| GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its first quarter 2025 financial results after U.S. markets close on Wednesday, May 7, 2025. GoodRx management will also hold a conference call and webcast the following morning, Thursday, May 8, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business out. |
businesswire.com |
2025-04-09 20:05:00 |
Czytaj oryginał (ang.) |
| GoodRx Stock Tumbles Despite Launching New Retail Pharmacy Platform |
GDRX rolls out a new e-commerce platform connecting users to top retail pharmacies, aiming to boost savings, improve access, and expand its digital health services. |
zacks.com |
2025-04-08 17:01:17 |
Czytaj oryginał (ang.) |
| GoodRx Introduces New E-commerce Experience for Retail Pharmacies |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced a new e-commerce experience for retail pharmacies that improves how consumers get their medications via the GoodRx platform. The company is launching the experience with Midwest-based retailer Hy-Vee. Now, when a person searches for their medication on GoodRx and selects Hy-Vee as their preferred pharmacy, the system will check for medication inventory, validate. |
businesswire.com |
2025-04-03 13:00:00 |
Czytaj oryginał (ang.) |
| GoodRx: Great Value For Patient Investors (Upgrade) |
GoodRx is a great small-cap value stock to buy amid the recent downturn. I'm upgrading the stock to a buy. GoodRx showcases strong adjusted EBITDA despite slower growth, making it an attractive target for private equity deals as public equities become less appealing. The company's new CEO is driving a wholesale change in business strategy, chasing relationships directly with pharmaceutical manufacturers. |
seekingalpha.com |
2025-03-24 18:16:26 |
Czytaj oryginał (ang.) |
| GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement, effective immediately. Aaron will be responsible for the management and financial performance of GoodRx's Rx Marketplace offering, working with key retail pharmacy, pharmacy benefit manager (PBM), employer, and man. |
businesswire.com |
2025-03-17 11:00:00 |
Czytaj oryginał (ang.) |
| GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today released a new report, The Prescription Drug Gender Divide, detailing how women shoulder a significantly greater out-of-pocket cost burden than men. The data shows that in 2024, women spent $8.8 billion – or 30% – more than men on out-of-pocket prescription costs. Combined with the common responsibilities of managing a career, family planning, and caregiving, women are le. |
businesswire.com |
2025-03-10 11:00:00 |
Czytaj oryginał (ang.) |
| GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales |
GoodRx Holdings Inc. GDRX reported fourth-quarter revenue of $198.6 million, up slightly by 1% year over year, missing the management guidance of around $200 million and consensus of $199.75 million. |
benzinga.com |
2025-02-27 15:41:33 |
Czytaj oryginał (ang.) |
| GoodRx Holdings, Inc. (GDRX) Q4 2024 Earnings Call Transcript |
GoodRx Holdings, Inc. (NASDAQ:GDRX ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants Aubrey Reynolds - Director, IR Wendy Barnes - CEO Chris McGinnis - CFO Conference Call Participants Lisa Gill - J.P. Morgan John Ransom - RJF Charles Rhyee - TD Cowen Michael Cherny - Leerink Partners Jenny Cao - Truist Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Securities Steven Valiquette - Mizuho Securities Jay Jin - Morgan Stanley George Hill - Deutsche Bank Allen Lutz - Bank of America Operator Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Fourth Quarter and Full Year 2024 Earnings Call. |
seekingalpha.com |
2025-02-27 13:37:49 |
Czytaj oryginał (ang.) |
| Here's What Key Metrics Tell Us About GoodRx (GDRX) Q4 Earnings |
While the top- and bottom-line numbers for GoodRx (GDRX) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2025-02-27 12:36:03 |
Czytaj oryginał (ang.) |
| GoodRx Holdings, Inc. (GDRX) Q4 Earnings Match Estimates |
GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.08 per share a year ago. |
zacks.com |
2025-02-27 10:20:24 |
Czytaj oryginał (ang.) |
| GoodRx Reports Fourth Quarter and Full Year 2024 Results |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has released its financial results for the fourth quarter and full year of 2024. Fourth Quarter 2024 Highlights Revenue1 of $198.6 million Net income of $6.7 million; Net income margin of 3.4% Adjusted Net Income1 of $34.7 million; Adjusted Net Income Margin1 of 17.5% Adjusted EBITDA1 of $67.1 million; Adjusted EBITDA. |
businesswire.com |
2025-02-27 08:05:00 |
Czytaj oryginał (ang.) |
| Insights Into GoodRx (GDRX) Q4: Wall Street Projections for Key Metrics |
Beyond analysts' top -and-bottom-line estimates for GoodRx (GDRX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024. |
zacks.com |
2025-02-25 12:20:52 |
Czytaj oryginał (ang.) |
| GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading medication savings platform in the U.S., today announced its drug savings platform residing with Amazon Web Services (AWS) has earned certified status for 2025 by HITRUST for information security. This milestone underscores GoodRx's dedication to safeguarding data and maintaining specific standards of cybersecurity in healthcare. HITRUST i1 Certification demonstrates that GoodRx's drug savings platform is leveraging a set. |
businesswire.com |
2025-02-18 11:00:00 |
Czytaj oryginał (ang.) |
| GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced that Christopher A. McGinnis has been appointed as Chief Financial Officer, effective February 4, 2025. Chris brings 30 years of extensive financial experience across the healthcare industry to his new role. Chris will join GoodRx following his role as CEO of CitizensRx, where he led the company in providing pharmacy benefit management services to commercial clien. |
businesswire.com |
2025-02-05 18:05:00 |
Czytaj oryginał (ang.) |
| Scott Wagner Joins GoodRx Board of Directors |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that Scott Wagner has joined its Board of Directors, effective January 21, 2025. Mr. Wagner, who recently led GoodRx as its Interim Chief Executive Officer from April 2023 to January 2025, has been appointed as Co-Chair of the Board and will serve alongside existing Co-Chair Trevor Bezdek. Wagner joins. |
businesswire.com |
2025-01-22 19:00:00 |
Czytaj oryginał (ang.) |
| GoodRx CFO Karsten Voermann to Resign for Personal Reasons |
GoodRx Holdings disclosed Monday (Jan. 13) that its chief financial officer, Karsten Voermann, submitted his resignation Tuesday (Jan. 7), effective Friday (Jan. 16). The company attributed the resignation to “personal reasons” in a Monday filing with the Securities and Exchange Commission. |
pymnts.com |
2025-01-13 20:00:20 |
Czytaj oryginał (ang.) |
| GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is offering free online healthcare provider visits to California residents impacted by the wildfires devastating Los Angeles County. Starting today, Angelenos can use the code LA-GOODRX-CARE to be seen by a licensed medical provider on GoodRx Care for a variety of conditions. Hundreds of thousands of Californians have been impacted by the wildfires, which may p. |
businesswire.com |
2025-01-10 13:00:00 |
Czytaj oryginał (ang.) |
| GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced a new GoodRx for Pets experience that provides a more affordable and convenient way for Americans to access pet medications. Through GoodRx for Pets, pet owners can find savings and have pet medications delivered right to their door. GoodRx for Pets provides a seamless experience for pet owners, combining convenience, affordability, and accessibility in one place. |
businesswire.com |
2025-01-07 11:00:00 |
Czytaj oryginał (ang.) |
| GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 15, 2025 at 9:45 a.m. Pacific Time (12:45 p.m. Eastern Time). A live webcast will be available on the Company's Investor Relations website, https://investors. |
businesswire.com |
2024-12-18 18:05:00 |
Czytaj oryginał (ang.) |
| GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced that Wendy Barnes has been appointed as President and Chief Executive Officer, effective January 1, 2025. Wendy brings more than 30 years of leadership experience across the pharmacy and medical benefit industry to her new role. Wendy will join GoodRx following her role as CEO of RxBenefits, where she led the company in providing pharmacy benefit su. |
businesswire.com |
2024-12-16 18:05:00 |
Czytaj oryginał (ang.) |
| Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says |
Prescription fills for blockbuster weight loss medications in the U.S. more than doubled in 2024, even with limited insurance coverage and high out-of-pocket costs for the treatments. That's according to new data from drug savings company GoodRx, which examined fill trends and spending patterns for weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound. |
cnbc.com |
2024-12-05 11:00:01 |
Czytaj oryginał (ang.) |
| GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today released a new Weight Loss Medications Tracker that provides an inside look at fill trends and spending patterns for weight loss medications across the U.S. The company found that limited insurance coverage and high out-of-pocket costs aren't slowing down interest in popular drugs used for weight loss such as Mounjaro, Ozempic, Wegovy, and Zepbound. In fact, some of these p. |
businesswire.com |
2024-12-05 11:00:00 |
Czytaj oryginał (ang.) |
| GoodRx initiated with a Neutral at Mizuho |
Mizuho analyst Steven Valiquette initiated coverage of GoodRx with a Neutral rating and $5 price target. Following an "upbeat analyst meeting" in May that included 6%-12% revenue compound annual growth rate guidance for 2024-2026, store closures announced this year by several large retail drug chains now negatively impact GoodRx's second half of 2024 and 2025 outlook, says the analyst, who believes this has already put 2026 guidance "in jeopardy." |
https://thefly.com |
2024-12-03 18:32:26 |
Czytaj oryginał (ang.) |
| GoodRx Helps Announces Recipients of 2024 Students for Healthcare Equity Scholarship |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Helps, a 501(c)(3) nonprofit organization seeking to address health inequities across the country, has selected its 2024 Students for Healthcare Equity Scholarship recipients. The scholarship program was created to encourage culturally responsive healthcare by providing financial assistance to healthcare students from underrepresented groups. To date, GoodRx Helps has granted $325,000 in scholarships to students advocating for equitable access to he. |
businesswire.com |
2024-11-18 11:00:00 |
Czytaj oryginał (ang.) |
| Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm |
NEW YORK , Nov. 13, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of GoodRx Holdings, Inc. (NASDAQ: GDRX) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, GoodRx insiders caused the company to misrepresent or fail to disclose that (1) while Kroger accounted for less than 5% of the pharmacies accepting GoodRx discounts, Kroger was responsible for nearly 25% of GoodRx's total prescription transactions revenue (the Company's primary revenue stream); and (2) Kroger could unilaterally cease accepting GoodRx discounts, cutting off some or all of GoodRx's revenues for purchases at Kroger's pharmacies; and (3) as a result, representations about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis. |
prnewswire.com |
2024-11-13 14:38:00 |
Czytaj oryginał (ang.) |
| GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm |
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc. (NASDAQ: GDRX) on behalf of long-term stockholders following a class action complaint that was filed against GoodRx on April 22, 2024 with a Class Period from September 23, 2020, to November 8, 2022. Our investigation concerns whether the board of directors of GoodRx have breached their fiduciary duties to the company. |
globenewswire.com |
2024-11-12 23:00:00 |
Czytaj oryginał (ang.) |
| Why GoodRx Holdings Stock Was Sinking This Week |
The company is growing key fundamentals. However, the improvements weren't enough to impress the market. |
fool.com |
2024-11-08 09:15:09 |
Czytaj oryginał (ang.) |
| GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript |
GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript |
seekingalpha.com |
2024-11-07 16:14:19 |
Czytaj oryginał (ang.) |
| GoodRx (GDRX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates |
While the top- and bottom-line numbers for GoodRx (GDRX) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2024-11-07 12:35:53 |
Czytaj oryginał (ang.) |
| GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings and Revenue Estimates |
GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.06 per share a year ago. |
zacks.com |
2024-11-07 10:26:12 |
Czytaj oryginał (ang.) |
| GoodRx Reports Third Quarter 2024 Results |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has released its financial results for the third quarter of 2024. Third Quarter 2024 Highlights Revenue1 and Adjusted Revenue1 of $195.3 million Net income of $4.0 million; Net income margin of 2.0% Adjusted Net Income1 of $31.9 million; Adjusted Net Income Margin1 of 16.4% Adjusted EBITDA1 of $65.0 million; Adjusted. |
businesswire.com |
2024-11-07 08:05:00 |
Czytaj oryginał (ang.) |
| GoodRx (GDRX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates |
Beyond analysts' top -and-bottom-line estimates for GoodRx (GDRX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024. |
zacks.com |
2024-11-06 12:20:39 |
Czytaj oryginał (ang.) |
| GoodRx and CVS Sued for Suppressing Pharmacy Reimbursement |
Smaller pharmacies are accusing GoodRx and CVS of colluding to suppress generic prescription drug reimbursements. As Reuters reported Tuesday (Nov. 5), drug coupon aggregator GoodRx and a pair of pharmacy benefit managers (PBMs) — CVS's Caremark unit and Express Scripts — have all been named in at least three lawsuits by independent pharmacies. |
pymnts.com |
2024-11-05 17:44:33 |
Czytaj oryginał (ang.) |
| GoodRx to Participate in Upcoming Investor Conferences |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences: UBS 2024 Global Healthcare Conference in Rancho Palos Verdes, CA, on Tuesday, November 12, 2024 at 2 p.m. Eastern Time (11 a.m. Pacific Time) Citi 2024 Global Healthcare Conference in Miami, FL, on Thursday,. |
businesswire.com |
2024-11-04 18:05:00 |
Czytaj oryginał (ang.) |
| Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm |
NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of GoodRx Holdings, Inc. (NASDAQ: GDRX) breached their fiduciary duties to shareholders. |
globenewswire.com |
2024-10-31 17:17:00 |
Czytaj oryginał (ang.) |
| GoodRx Announces New Affordability Programs for Menopause Hormone Therapies |
SANTA MONICA, Calif.--(BUSINESS WIRE)--Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the availability of new affordability programs for menopause hormone therapies by Pfizer. Through the reach and scale of the GoodRx platform, these programs are broadening access and affordability of crucial medications for women. New research from GoodRx shows menopause medications have increased in list price by 58% since 2014. And according to a recent study,. |
businesswire.com |
2024-10-23 13:00:00 |
Czytaj oryginał (ang.) |
| GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, November 7, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference. |
businesswire.com |
2024-10-10 21:41:00 |
Czytaj oryginał (ang.) |
| GoodRx Holdings: Failing To Gain Much Traction |
Today, we are circling back on GoodRx Holdings, which offers a platform for comparing prescription drug prices. The company also enables their customers to benefit from negotiated prices through GoodRx codes that are used to save money on prescriptions. The stock has a bit of a rocky ride since forward guidance disappointed following second-quarter results. |
seekingalpha.com |
2024-10-08 18:46:53 |
Czytaj oryginał (ang.) |